Widecells Share Price (WDC)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Widecells Group	LSE:WDC	London	Ordinary Share	GB00BD060S65	ORD GBP0.0025

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+0.00p	+0.00%	2.65p	0	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
2.60p		2.70p	2.65p	2.65p	2.65p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Health Care Equipment & Services	0.05	-2.81	-5.00		1.7

Related Shares
Smith & Nephew (SN.), NMC Health (NMC), Deltex Medical (DEMG), Physiomics (PYC)

Widecells (WDC) Latest News

Widecells News

Date	Time	Source	Headline
09/7/2018	11:26	ALNC	WideCells Appoints Jeremy Lea As Chief Operating Officer
09/7/2018	07:08	ALNCF	Alliance News Flash Headline
09/7/2018	07:01	UKREG	WideCells Group PLC Board Changes
09/7/2018	07:00	UKREG	WideCells Group PLC Holding(s) in Company
29/6/2018	15:00	UKREG	WideCells Group PLC Result of AGM
28/6/2018	10:30	UKREG	WideCells Group PLC Result of General Meeting
15/6/2018	07:00	UKREG	WideCells Group PLC Align Research Initiation of Coverage
12/6/2018	18:25	UKREG	WideCells Group PLC Prospectus and Notice of General Meeting
11/6/2018	12:13	ALNC	WideCells Shares Restored As It Raises GBP2.0 Million In Placing (ALLISS)
11/6/2018	09:00	UKREG	WideCells Group PLC Live Market Bookbuild Closes

More Widecells News

Widecells Takeover Rumours

Widecells (WDC) Share Charts

1 Year Widecells Chart

1 Month Widecells Chart

Intraday Widecells Chart

Widecells (WDC) Discussions and Chat

Widecells Forums and Chat

Date	Time	Title	Posts
18/7/2018	18:14	WideCells Group	228
14/6/2018	12:39	Widecells Interview and Q&A	-
05/4/2018	12:01	Widecells Group INTERVIEW	-
26/3/2018	08:34	INTERVIEW: Widecells Group PLC	1
22/8/2017	21:41	Revenue lift off	1

Add a New Thread

Widecells (WDC) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Widecells trades in real-time

Widecells (WDC) Top Chat Posts

Date	Subject
19/7/2018 09:20	Widecells Daily Update: Widecells Group is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker WDC. The last closing price for Widecells was 2.65p. Widecells Group has a 4 week average price of 2.60p and a 12 week average price of 2.60p. The 1 year high share price is 15p while the 1 year low share price is currently 2.60p. There are currently 64,821,010 shares in issue and the average daily traded volume is 201,521 shares. The market capitalisation of Widecells Group is £1,717,756.77. Read Full Thread Reply
25/6/2018 22:18	rampair: After a few years you could reward yourself quite well if you’d built your business, your share price would respond. Read Full Thread Follow Reply
15/6/2018 07:42	longshanks: Do you work for Align, Imhustdandy?I read the note, and it is great that they think the company is worth as much as they do, but there is very little content to what they write.The release of an RNS about a "research" note by a paid hack is also rather odd. Seems like a case of Fake News to me.Clearly the company needs to raise more cash this year and they are keen to get the share price higher to minimise dilution. However the best way to demonstrate a prospective 2020 PER of 1.1 is to actually deliver some revenue streams. Sad too for shareholders that some of their valuable investment cash is being spent in this way.The only highlight is that they have a couple of fund managers interested enough to put some pin money into this. I suspect it is just that, a little bit of risk money to give them a chance on the 100:1 runner at Haydock.For me though, it is still a case of: Avoid. Read Full Thread Follow Reply
14/6/2018 18:47	hobnob1: Why on earth does this board think it should be paid? They have delivered no profits, no revenue and have crashed the share price. If they want a job, go and apply for one at a profitable company. Read Full Thread Follow Reply
06/6/2018 16:19	balance1: The Chairman's letter fails to mention the massive destruction of shareholder value through the collapse of the share price. You would have thought the Chairman's review would explain why the company completely ran out of money, despite being fully funded up to its headroom limits, and how he will ensure this doesn't happen again. Read Full Thread Follow Reply
20/3/2018 14:46	237gmoney: Hi All, I'm new here. Can anyone tell me who the Reinsurance partners are on the Cell Plan? I can't find the name of the company anywhere.... Only that the cellplan costs £170 a year and £50 of this will go towards Reinsurance costs. They say it is a market leading Reinsurer but if you tell me the name I can be the judge of that. Also if we knew who it was it would be a big selling point for the company. I like the company although the share price has taken a little knock last 6 weeks? Cashflow issues? Read Full Thread Follow Reply
31/10/2017 10:03	hobnob1: timbo003, I have a couple of questions if you are going 1) They are saying revenue is the big story now, so how much revenue has been brought in so far? How much revenue do they think will come in over the next six months? Will the company be providing regular updates so shareholders can track this 2) The company has developed enormously over the last 12 months, but the share price hasn't gone anywhere, and there are virtually no buyers of the stock. Why is this? Agree with pranchalee, this could be a really special company. Just wanting to understand how quickly they can translate all this corporate development into shareholder return. So far the stock has been pretty disappointing. Read Full Thread Follow Reply
26/10/2017 13:32	pranchalee: Awards and running marathons are all very well but how about getting the share price moving Read Full Thread Follow Reply
17/10/2017 18:32	nohead: MM, yes I have met these guys and really like the company. They are smart and ambitious. They are at the stage of focussing 100% on building positive cash flow, and then translating that into share price performance. I think they will do both. Read Full Thread Follow Reply
25/9/2017 10:11	iphone8: A very interesting new presentation has gone up on the Widecells website this morning. It goes into far more detail on revenue growth than any previous presentations or research notes. The great thing about the company is that it is providing a range of services to the fast-growing stem cell industry, but it is not a stem cell technology company itself, so it doesn’t carry that risk.There are now five different engines of revenue growth in the company: the stem cell insurance product, the stem cell storage facility, stem cell research services, stem cell education and a cell related detail product. Working through the presentation numbers (and making a few guesstimates) It looks like the company should make around £2m in “Year 1”, £5m in year 2, and £8m+ in year 3. It is not clear when “year 1” starts. But from other RNSs, Year 1 should be starting about now, or may have already started. There are some hints at cost of sales in the company’s margin estimates, but we don’t know how overall costs will rise. However, from these figures, it is a fair bet that the company will break even in 2018, possibly in the first half, and start turning a substantial profit in 2019. The presentation lacked any kind of peer group analysis showing the valuation of similar-style high growth start-ups on the LSE. However it is likely that these will show valuations of a multiple of Widecell’s trifling £8m valuation, especially when it gets into profit. As these various revenue streams “go live”, the market should start to pick up on this, especially if the company now starts to turn its attention to an aggressive share promotion programme. They could probably do with updating their broker research soon, as the last one is already looking rather dated. If these revenues come through, then the share price ought to re-rate by a multiple over the next 12 month, as the current market cap is so tiny Great to see the company coming out punching. Read Full Thread Follow Reply

Widecells share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:42 V: D:20180719 23:19:18